April 2 (Reuters) - Regeneron Pharmaceuticals Inc REGN.O:
REGENERON COLLABORATES WITH TRINETX TO ACCESS DE-IDENTIFIED ELECTRONIC HEALTH RECORDS OF 300 MILLION PATIENTS TO DRIVE RESEARCH AND PRODUCT DEVELOPMENT IN LIFE SCIENCES AND DIGITAL HEALTH SOLUTIONS